Selected research
Market Analysis & Forecast
Global AI Medical Diagnosis Tool Market Analysis and Forecast 2026-2032
Market perspective
The global AI Medical Diagnosis Tool market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for AI Medical Diagnosis Tool is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for AI Medical Diagnosis Tool is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for AI Medical Diagnosis Tool is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for AI Medical Diagnosis Tool is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of AI Medical Diagnosis Tool include IBM Watson Health, Tempus, PathAI, Zebra Medical Vision, Aidoc, Arterys, Enlitic, Freenome and Qure.ai, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for AI Medical Diagnosis Tool, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of AI Medical Diagnosis Tool, also provides the revenue of main regions and countries. Of the upcoming market potential for AI Medical Diagnosis Tool, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the AI Medical Diagnosis Tool revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI Medical Diagnosis Tool market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI Medical Diagnosis Tool revenue, projected growth trends, production technology, application and end-user industry.
AI Medical Diagnosis Tool Segment by Company
IBM Watson Health
Tempus
PathAI
Zebra Medical Vision
Aidoc
Arterys
Enlitic
Freenome
Qure.ai
Viz.ai
AI Medical Diagnosis Tool Segment by Type
Machine Learning (ML)
Natural Language Processing (NLP)
Computer Vision
Robotic Process Automation (RPA)
AI Medical Diagnosis Tool Segment by Application
Hospitals and Clinics
Diagnostic Centers
Home Healthcare
AI Medical Diagnosis Tool Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Medical Diagnosis Tool market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Medical Diagnosis Tool and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Medical Diagnosis Tool.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of AI Medical Diagnosis Tool in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of AI Medical Diagnosis Tool company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Medical Diagnosis Tool revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Machine Learning (ML)
- Natural Language Processing (NLP)
- Computer Vision
- Robotic Process Automation (RPA)
Applications
- Hospitals and Clinics
- Diagnostic Centers
- Home Healthcare
Companies covered
- IBM Watson Health
- Tempus
- PathAI
- Zebra Medical Vision
- Aidoc
- Arterys
- Enlitic
- Freenome
- Qure.ai
- Viz.ai
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 AI Medical Diagnosis Tool Market by Type
- 1.2.1 Global AI Medical Diagnosis Tool Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Machine Learning (ML)
- 1.2.3 Natural Language Processing (NLP)
- 1.2.4 Computer Vision
- 1.2.5 Robotic Process Automation (RPA)
- 1.3 AI Medical Diagnosis Tool Market by Application
- 1.3.1 Global AI Medical Diagnosis Tool Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospitals and Clinics
- 1.3.3 Diagnostic Centers
- 1.3.4 Home Healthcare
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 AI Medical Diagnosis Tool Market Dynamics
- 2.1 AI Medical Diagnosis Tool Industry Trends
- 2.2 AI Medical Diagnosis Tool Industry Drivers
- 2.3 AI Medical Diagnosis Tool Industry Opportunities and Challenges
- 2.4 AI Medical Diagnosis Tool Industry Restraints
3 Global Growth Perspective
- 3.1 Global AI Medical Diagnosis Tool Market Perspective (2021-2032)
- 3.2 Global AI Medical Diagnosis Tool Growth Trends by Region
- 3.2.1 Global AI Medical Diagnosis Tool Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global AI Medical Diagnosis Tool Market Size by Region (2021-2026)
- 3.2.3 Global AI Medical Diagnosis Tool Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global AI Medical Diagnosis Tool Revenue by Players
- 4.1.1 Global AI Medical Diagnosis Tool Revenue by Players (2021-2026)
- 4.1.2 Global AI Medical Diagnosis Tool Revenue Market Share by Players (2021-2026)
- 4.1.3 Global AI Medical Diagnosis Tool Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global AI Medical Diagnosis Tool Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global AI Medical Diagnosis Tool Key Players Headquarters & Area Served
- 4.4 Global AI Medical Diagnosis Tool Players, Product Type & Application
- 4.5 Global AI Medical Diagnosis Tool Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global AI Medical Diagnosis Tool Market CR5 and HHI
- 4.6.3 2025 AI Medical Diagnosis Tool Tier 1, Tier 2, and Tier 3
5 AI Medical Diagnosis Tool Market Size by Type
- 5.1 Global AI Medical Diagnosis Tool Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global AI Medical Diagnosis Tool Revenue by Type (2021-2032)
- 5.3 Global AI Medical Diagnosis Tool Revenue Market Share by Type (2021-2032)
6 AI Medical Diagnosis Tool Market Size by Application
- 6.1 Global AI Medical Diagnosis Tool Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global AI Medical Diagnosis Tool Revenue by Application (2021-2032)
- 6.3 Global AI Medical Diagnosis Tool Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 IBM Watson Health
- 7.1.1 IBM Watson Health Company Information
- 7.1.2 IBM Watson Health Business Overview
- 7.1.3 IBM Watson Health AI Medical Diagnosis Tool Revenue and Gross Margin (2021-2026)
- 7.1.4 IBM Watson Health AI Medical Diagnosis Tool Product Portfolio
- 7.1.5 IBM Watson Health Recent Developments
- 7.2 Tempus
- 7.2.1 Tempus Company Information
- 7.2.2 Tempus Business Overview
- 7.2.3 Tempus AI Medical Diagnosis Tool Revenue and Gross Margin (2021-2026)
- 7.2.4 Tempus AI Medical Diagnosis Tool Product Portfolio
- 7.2.5 Tempus Recent Developments
- 7.3 PathAI
- 7.3.1 PathAI Company Information
- 7.3.2 PathAI Business Overview
- 7.3.3 PathAI AI Medical Diagnosis Tool Revenue and Gross Margin (2021-2026)
- 7.3.4 PathAI AI Medical Diagnosis Tool Product Portfolio
- 7.3.5 PathAI Recent Developments
- 7.4 Zebra Medical Vision
- 7.4.1 Zebra Medical Vision Company Information
- 7.4.2 Zebra Medical Vision Business Overview
- 7.4.3 Zebra Medical Vision AI Medical Diagnosis Tool Revenue and Gross Margin (2021-2026)
- 7.4.4 Zebra Medical Vision AI Medical Diagnosis Tool Product Portfolio
- 7.4.5 Zebra Medical Vision Recent Developments
- 7.5 Aidoc
- 7.5.1 Aidoc Company Information
- 7.5.2 Aidoc Business Overview
- 7.5.3 Aidoc AI Medical Diagnosis Tool Revenue and Gross Margin (2021-2026)
- 7.5.4 Aidoc AI Medical Diagnosis Tool Product Portfolio
- 7.5.5 Aidoc Recent Developments
- 7.6 Arterys
- 7.6.1 Arterys Company Information
- 7.6.2 Arterys Business Overview
- 7.6.3 Arterys AI Medical Diagnosis Tool Revenue and Gross Margin (2021-2026)
- 7.6.4 Arterys AI Medical Diagnosis Tool Product Portfolio
- 7.6.5 Arterys Recent Developments
- 7.7 Enlitic
- 7.7.1 Enlitic Company Information
- 7.7.2 Enlitic Business Overview
- 7.7.3 Enlitic AI Medical Diagnosis Tool Revenue and Gross Margin (2021-2026)
- 7.7.4 Enlitic AI Medical Diagnosis Tool Product Portfolio
- 7.7.5 Enlitic Recent Developments
- 7.8 Freenome
- 7.8.1 Freenome Company Information
- 7.8.2 Freenome Business Overview
- 7.8.3 Freenome AI Medical Diagnosis Tool Revenue and Gross Margin (2021-2026)
- 7.8.4 Freenome AI Medical Diagnosis Tool Product Portfolio
- 7.8.5 Freenome Recent Developments
- 7.9 Qure.ai
- 7.9.1 Qure.ai Company Information
- 7.9.2 Qure.ai Business Overview
- 7.9.3 Qure.ai AI Medical Diagnosis Tool Revenue and Gross Margin (2021-2026)
- 7.9.4 Qure.ai AI Medical Diagnosis Tool Product Portfolio
- 7.9.5 Qure.ai Recent Developments
- 7.10 Viz.ai
- 7.10.1 Viz.ai Company Information
- 7.10.2 Viz.ai Business Overview
- 7.10.3 Viz.ai AI Medical Diagnosis Tool Revenue and Gross Margin (2021-2026)
- 7.10.4 Viz.ai AI Medical Diagnosis Tool Product Portfolio
- 7.10.5 Viz.ai Recent Developments
8 North America
- 8.1 North America AI Medical Diagnosis Tool Revenue (2021-2032)
- 8.2 North America AI Medical Diagnosis Tool Revenue by Type (2021-2032)
- 8.2.1 North America AI Medical Diagnosis Tool Revenue by Type (2021-2026)
- 8.2.2 North America AI Medical Diagnosis Tool Revenue by Type (2027-2032)
- 8.3 North America AI Medical Diagnosis Tool Revenue Share by Type (2021-2032)
- 8.4 North America AI Medical Diagnosis Tool Revenue by Application (2021-2032)
- 8.4.1 North America AI Medical Diagnosis Tool Revenue by Application (2021-2026)
- 8.4.2 North America AI Medical Diagnosis Tool Revenue by Application (2027-2032)
- 8.5 North America AI Medical Diagnosis Tool Revenue Share by Application (2021-2032)
- 8.6 North America AI Medical Diagnosis Tool Revenue by Country
- 8.6.1 North America AI Medical Diagnosis Tool Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America AI Medical Diagnosis Tool Revenue by Country (2021-2026)
- 8.6.3 North America AI Medical Diagnosis Tool Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe AI Medical Diagnosis Tool Revenue (2021-2032)
- 9.2 Europe AI Medical Diagnosis Tool Revenue by Type (2021-2032)
- 9.2.1 Europe AI Medical Diagnosis Tool Revenue by Type (2021-2026)
- 9.2.2 Europe AI Medical Diagnosis Tool Revenue by Type (2027-2032)
- 9.3 Europe AI Medical Diagnosis Tool Revenue Share by Type (2021-2032)
- 9.4 Europe AI Medical Diagnosis Tool Revenue by Application (2021-2032)
- 9.4.1 Europe AI Medical Diagnosis Tool Revenue by Application (2021-2026)
- 9.4.2 Europe AI Medical Diagnosis Tool Revenue by Application (2027-2032)
- 9.5 Europe AI Medical Diagnosis Tool Revenue Share by Application (2021-2032)
- 9.6 Europe AI Medical Diagnosis Tool Revenue by Country
- 9.6.1 Europe AI Medical Diagnosis Tool Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe AI Medical Diagnosis Tool Revenue by Country (2021-2026)
- 9.6.3 Europe AI Medical Diagnosis Tool Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China AI Medical Diagnosis Tool Revenue (2021-2032)
- 10.2 China AI Medical Diagnosis Tool Revenue by Type (2021-2032)
- 10.2.1 China AI Medical Diagnosis Tool Revenue by Type (2021-2026)
- 10.2.2 China AI Medical Diagnosis Tool Revenue by Type (2027-2032)
- 10.3 China AI Medical Diagnosis Tool Revenue Share by Type (2021-2032)
- 10.4 China AI Medical Diagnosis Tool Revenue by Application (2021-2032)
- 10.4.1 China AI Medical Diagnosis Tool Revenue by Application (2021-2026)
- 10.4.2 China AI Medical Diagnosis Tool Revenue by Application (2027-2032)
- 10.5 China AI Medical Diagnosis Tool Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia AI Medical Diagnosis Tool Revenue (2021-2032)
- 11.2 Asia AI Medical Diagnosis Tool Revenue by Type (2021-2032)
- 11.2.1 Asia AI Medical Diagnosis Tool Revenue by Type (2021-2026)
- 11.2.2 Asia AI Medical Diagnosis Tool Revenue by Type (2027-2032)
- 11.3 Asia AI Medical Diagnosis Tool Revenue Share by Type (2021-2032)
- 11.4 Asia AI Medical Diagnosis Tool Revenue by Application (2021-2032)
- 11.4.1 Asia AI Medical Diagnosis Tool Revenue by Application (2021-2026)
- 11.4.2 Asia AI Medical Diagnosis Tool Revenue by Application (2027-2032)
- 11.5 Asia AI Medical Diagnosis Tool Revenue Share by Application (2021-2032)
- 11.6 Asia AI Medical Diagnosis Tool Revenue by Country
- 11.6.1 Asia AI Medical Diagnosis Tool Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia AI Medical Diagnosis Tool Revenue by Country (2021-2026)
- 11.6.3 Asia AI Medical Diagnosis Tool Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA AI Medical Diagnosis Tool Revenue (2021-2032)
- 12.2 SAMEA AI Medical Diagnosis Tool Revenue by Type (2021-2032)
- 12.2.1 SAMEA AI Medical Diagnosis Tool Revenue by Type (2021-2026)
- 12.2.2 SAMEA AI Medical Diagnosis Tool Revenue by Type (2027-2032)
- 12.3 SAMEA AI Medical Diagnosis Tool Revenue Share by Type (2021-2032)
- 12.4 SAMEA AI Medical Diagnosis Tool Revenue by Application (2021-2032)
- 12.4.1 SAMEA AI Medical Diagnosis Tool Revenue by Application (2021-2026)
- 12.4.2 SAMEA AI Medical Diagnosis Tool Revenue by Application (2027-2032)
- 12.5 SAMEA AI Medical Diagnosis Tool Revenue Share by Application (2021-2032)
- 12.6 SAMEA AI Medical Diagnosis Tool Revenue by Country
- 12.6.1 SAMEA AI Medical Diagnosis Tool Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA AI Medical Diagnosis Tool Revenue by Country (2021-2026)
- 12.6.3 SAMEA AI Medical Diagnosis Tool Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst